Stephen T. Worland - Jan 20, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
President and Chief Executive, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Stock symbol
EFTR
Transactions as of
Jan 20, 2022
Transactions value $
$0
Form type
4
Date filed
1/24/2022, 07:04 PM
Previous filing
Aug 27, 2021
Next filing
May 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +521K $0.00 521K Jan 20, 2022 Common Stock 521K $6.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 20, 2022 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.